File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1038/s41579-021-00535-6
- Scopus: eid_2-s2.0-85103203161
- PMID: 33753932
- WOS: WOS:000631482900001
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Transmissibility and transmission of respiratory viruses
Title | Transmissibility and transmission of respiratory viruses |
---|---|
Authors | |
Issue Date | 2021 |
Publisher | Nature Research: Nature Reviews Journals. The Journal's web site is located at http://www.nature.com/nrmicro/ |
Citation | Nature Reviews Microbiology, 2021, v. 19 n. 8, p. 528-545 How to Cite? |
Abstract | Human respiratory virus infections lead to a spectrum of respiratory symptoms and disease severity, contributing to substantial morbidity, mortality and economic losses worldwide, as seen in the COVID-19 pandemic. Belonging to diverse families, respiratory viruses differ in how easy they spread (transmissibility) and the mechanism (modes) of transmission. Transmissibility as estimated by the basic reproduction number (R-0) or secondary attack rate is heterogeneous for the same virus. Respiratory viruses can be transmitted via four major modes of transmission: direct (physical) contact, indirect contact (fomite), (large) droplets and (fine) aerosols. We know little about the relative contribution of each mode to the transmission of a particular virus in different settings, and how its variation affects transmissibility and transmission dynamics. Discussion on the particle size threshold between droplets and aerosols and the importance of aerosol transmission for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and influenza virus is ongoing. Mechanistic evidence supports the efficacies of non-pharmaceutical interventions with regard to virus reduction; however, more data are needed on their effectiveness in reducing transmission. Understanding the relative contribution of different modes to transmission is crucial to inform the effectiveness of non-pharmaceutical interventions in the population. Intervening against multiple modes of transmission should be more effective than acting on a single mode.
In this Review, Leung provides an overview of the transmissibility and modes of transmission of respiratory viruses, the viral, host and environmental determinants of transmission, and common non-pharmaceutical interventions for mitigating respiratory virus transmission. She also discusses the recent controversies over aerosol transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19. |
Description | Bronze open access |
Persistent Identifier | http://hdl.handle.net/10722/299077 |
ISSN | 2023 Impact Factor: 69.2 2023 SCImago Journal Rankings: 9.639 |
PubMed Central ID | |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Leung, NHL | - |
dc.date.accessioned | 2021-04-28T02:25:53Z | - |
dc.date.available | 2021-04-28T02:25:53Z | - |
dc.date.issued | 2021 | - |
dc.identifier.citation | Nature Reviews Microbiology, 2021, v. 19 n. 8, p. 528-545 | - |
dc.identifier.issn | 1740-1526 | - |
dc.identifier.uri | http://hdl.handle.net/10722/299077 | - |
dc.description | Bronze open access | - |
dc.description.abstract | Human respiratory virus infections lead to a spectrum of respiratory symptoms and disease severity, contributing to substantial morbidity, mortality and economic losses worldwide, as seen in the COVID-19 pandemic. Belonging to diverse families, respiratory viruses differ in how easy they spread (transmissibility) and the mechanism (modes) of transmission. Transmissibility as estimated by the basic reproduction number (R-0) or secondary attack rate is heterogeneous for the same virus. Respiratory viruses can be transmitted via four major modes of transmission: direct (physical) contact, indirect contact (fomite), (large) droplets and (fine) aerosols. We know little about the relative contribution of each mode to the transmission of a particular virus in different settings, and how its variation affects transmissibility and transmission dynamics. Discussion on the particle size threshold between droplets and aerosols and the importance of aerosol transmission for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and influenza virus is ongoing. Mechanistic evidence supports the efficacies of non-pharmaceutical interventions with regard to virus reduction; however, more data are needed on their effectiveness in reducing transmission. Understanding the relative contribution of different modes to transmission is crucial to inform the effectiveness of non-pharmaceutical interventions in the population. Intervening against multiple modes of transmission should be more effective than acting on a single mode. In this Review, Leung provides an overview of the transmissibility and modes of transmission of respiratory viruses, the viral, host and environmental determinants of transmission, and common non-pharmaceutical interventions for mitigating respiratory virus transmission. She also discusses the recent controversies over aerosol transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19. | - |
dc.language | eng | - |
dc.publisher | Nature Research: Nature Reviews Journals. The Journal's web site is located at http://www.nature.com/nrmicro/ | - |
dc.relation.ispartof | Nature Reviews Microbiology | - |
dc.title | Transmissibility and transmission of respiratory viruses | - |
dc.type | Article | - |
dc.identifier.email | Leung, NHL: nanleung@connect.hku.hk | - |
dc.identifier.authority | Leung, NHL=rp02637 | - |
dc.description.nature | link_to_OA_fulltext | - |
dc.identifier.doi | 10.1038/s41579-021-00535-6 | - |
dc.identifier.pmid | 33753932 | - |
dc.identifier.pmcid | PMC7982882 | - |
dc.identifier.scopus | eid_2-s2.0-85103203161 | - |
dc.identifier.hkuros | 322274 | - |
dc.identifier.volume | 19 | - |
dc.identifier.issue | 8 | - |
dc.identifier.spage | 528 | - |
dc.identifier.epage | 545 | - |
dc.identifier.isi | WOS:000631482900001 | - |
dc.publisher.place | United Kingdom | - |